These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 31002491)

  • 41. Miltefosine Reduces the Cytolytic Activity and Virulence of
    Fiester SE; Arivett BA; Beckett AC; Wagner BR; Ohneck EJ; Schmidt RE; Grier JT; Actis LA
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30373804
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Trend of extensively drug-resistant Acinetobacter baumannii and the remaining therapeutic options: a multicenter study in Tehran, Iran over a 3-year period.
    Jasemi S; Douraghi M; Adibhesami H; Zeraati H; Rahbar M; Boroumand MA; Aliramezani A; Ghourchian S; Mohammadzadeh M
    Lett Appl Microbiol; 2016 Dec; 63(6):466-472. PubMed ID: 27626896
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii.
    Park GC; Choi JA; Jang SJ; Jeong SH; Kim CM; Choi IS; Kang SH; Park G; Moon DS
    Ann Lab Med; 2016 Mar; 36(2):124-30. PubMed ID: 26709259
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synergistic effect between nisin and polymyxin B against pandrug-resistant and extensively drug-resistant Acinetobacter baumannii.
    Thomas VM; Brown RM; Ashcraft DS; Pankey GA
    Int J Antimicrob Agents; 2019 May; 53(5):663-668. PubMed ID: 30880230
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Investigation of Colistin and Sulbactam Combination Effectivity in Multi Drug Resistant Acinetobacter baumannii Strains with Diagonal Gradient Strip Test Method.
    Hatipoglu H; Kilbas I; Kilic U; Yilmaz K; Koroglu M; Altindis M
    Clin Lab; 2018 Oct; 64(11):. PubMed ID: 30549991
    [No Abstract]   [Full Text] [Related]  

  • 46. Copper Resistance of the Emerging Pathogen Acinetobacter baumannii.
    Williams CL; Neu HM; Gilbreath JJ; Michel SL; Zurawski DV; Merrell DS
    Appl Environ Microbiol; 2016 Oct; 82(20):6174-6188. PubMed ID: 27520808
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pentamidine sensitizes Gram-negative pathogens to antibiotics and overcomes acquired colistin resistance.
    Stokes JM; MacNair CR; Ilyas B; French S; Côté JP; Bouwman C; Farha MA; Sieron AO; Whitfield C; Coombes BK; Brown ED
    Nat Microbiol; 2017 Mar; 2():17028. PubMed ID: 28263303
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fluorescence-Based Detection of Natural Transformation in Drug-Resistant Acinetobacter baumannii.
    Godeux AS; Lupo A; Haenni M; Guette-Marquet S; Wilharm G; Laaberki MH; Charpentier X
    J Bacteriol; 2018 Oct; 200(19):. PubMed ID: 30012729
    [No Abstract]   [Full Text] [Related]  

  • 49. Treatment options for multidrug-resistant nonfermenters.
    Briceño DF; Quinn JP; Villegas MV
    Expert Rev Anti Infect Ther; 2010 Mar; 8(3):303-15. PubMed ID: 20192684
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular characterization and antimicrobial susceptibility of Acinetobacter baumannii isolates obtained from two hospital outbreaks in Los Angeles County, California, USA.
    Warner WA; Kuang SN; Hernandez R; Chong MC; Ewing PJ; Fleischer J; Meng J; Chu S; Terashita D; English L; Chen W; Xu HH
    BMC Infect Dis; 2016 May; 16():194. PubMed ID: 27146090
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Activity of levofloxacin in combination with colistin against Acinetobacter baumannii: In vitro and in a Galleria mellonella model.
    Wei W; Yang H; Hu L; Ye Y; Li J
    J Microbiol Immunol Infect; 2017 Dec; 50(6):821-830. PubMed ID: 26725481
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Emergence of Aminoglycoside Resistance Due to armA methylase in Multi-drug Resistant Acinetobacter Baumannii Isolates in a University Hospital in Nepal.
    Shrestha S; Tada T; Shrestha B; Kirikae T; Ohara H; Rijal BP; Pokhrel BM; Sherchand JB
    J Nepal Health Res Counc; 2016 May; 14(33):72-76. PubMed ID: 27885285
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genetic basis of antibiotic resistance in pathogenic Acinetobacter species.
    Poirel L; Bonnin RA; Nordmann P
    IUBMB Life; 2011 Dec; 63(12):1061-7. PubMed ID: 21990280
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lipopolysaccharide loss produces partial colistin dependence and collateral sensitivity to azithromycin, rifampicin and vancomycin in Acinetobacter baumannii.
    García-Quintanilla M; Carretero-Ledesma M; Moreno-Martínez P; Martín-Peña R; Pachón J; McConnell MJ
    Int J Antimicrob Agents; 2015 Dec; 46(6):696-702. PubMed ID: 26391380
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Annual trends in antibiotic resistance of nosocomial Acinetobacter baumannii strains and the effect of synergistic antibiotic combinations.
    Tatman-Otkun M; Gürcan S; Ozer B; Shokrylanbaran N
    New Microbiol; 2004 Jan; 27(1):21-8. PubMed ID: 14964402
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Siderophore Conjugates of Daptomycin are Potent Inhibitors of Carbapenem Resistant Strains of Acinetobacter baumannii.
    Ghosh M; Lin YM; Miller PA; Möllmann U; Boggess WC; Miller MJ
    ACS Infect Dis; 2018 Oct; 4(10):1529-1535. PubMed ID: 30043609
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Novel phage lysin capable of killing the multidrug-resistant gram-negative bacterium Acinetobacter baumannii in a mouse bacteremia model.
    Lood R; Winer BY; Pelzek AJ; Diez-Martinez R; Thandar M; Euler CW; Schuch R; Fischetti VA
    Antimicrob Agents Chemother; 2015 Apr; 59(4):1983-91. PubMed ID: 25605353
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antibacterial Activity of Gold Nanoparticles Conjugated by Aminoglycosides Against
    Rad MR; Kazemian H; Yazdani F; Monfared MRZ; Rahdar H; Javadi A; Kodori M
    Recent Pat Antiinfect Drug Discov; 2018; 13(3):256-264. PubMed ID: 30152290
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Repurposing Screen Identifies Unconventional Drugs With Activity Against Multidrug Resistant
    Cheng YS; Sun W; Xu M; Shen M; Khraiwesh M; Sciotti RJ; Zheng W
    Front Cell Infect Microbiol; 2018; 8():438. PubMed ID: 30662875
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synergy between Active Efflux and Outer Membrane Diffusion Defines Rules of Antibiotic Permeation into Gram-Negative Bacteria.
    Krishnamoorthy G; Leus IV; Weeks JW; Wolloscheck D; Rybenkov VV; Zgurskaya HI
    mBio; 2017 Oct; 8(5):. PubMed ID: 29089426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.